Your session is about to expire
← Back to Search
Quality of Life Strategies After Stem Cell Transplant for Blood Diseases
Study Summary
This trial is studying two different approaches to see which one is better in improving quality of life and survival for patients who have undergone a stem cell transplant.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am being considered for a stem cell transplant to treat my blood disease.You can engage in light to moderate physical activity. In very rare cases, if you have a birth deformity or a previous injury that affects your ability to walk, you may not be able to participate.I am scheduled for a stem cell transplant from a donor within 3 weeks.My health score is 3 or higher, making me eligible for a cell transplant.I am scheduled for a donor lymphocyte infusion within 3 months after my transplant.I can walk up stairs without needing extra oxygen.I am 65 years old or older.I can walk safely and follow study rules despite my health issues.You are currently participating in another research study where the main focus is on measuring your quality of life.I plan to undergo specific cancer treatments after my transplant, approved by my doctor.I am over 50 and walk slower than 0.8 meters per second.
- Group 1: Arm II (CMC)
- Group 2: Arm I (SPC)
- Group 3: Arm III (SPC and CMC)
- Group 4: Arm IV (standard of care)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can people still join this trial program?
"Indeed, this trial is currently looking for 600 patients from 7 different locations, according to the information available on clinicaltrials.gov."
Could you tell me how many trial sites there are in total?
"Presently, this trial is running in Seattle, Houston, Palo Alto, and 7 other cities. To limit participant burden, it is ideal to pick a location nearest you."
What are the researchers hoping to learn from this clinical trial?
"The primary objective of this study is to evaluate survival rates after hematopoietic cell transplantation (HCT). Secondary objectives include duration of stay in the intensive care unit (ICU), cumulative incidence of relapse, and overall survival rates. Data will be collected over a period of Baseline to 90 days post-HCT, and comparisons will be made between the different experimental arms and the usual care only (UCO) arm using the log-rank test."
Share this study with friends
Copy Link
Messenger